Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neotherapuetics possibly has a breakthrough drug - NEOT -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (179)	8/13/2001 1:47:34 PM
From: Nikole Wollerstein	Read Replies (1) \| Respond to of 204

It is very interesting review about the role of the purines in the brain development regeneration sciencedirect.com I am not sure you can get access to it for free: I got it through UCSF library International Journal of Developmental Neuroscience Copyright © 2001 International Society for Developmental Neuroscience Volume 19, Issue 4, Pages 395-414 (July 2001) Involvement of astrocytes in purine-mediated reparative processes in the brain. R. Ciccarelli, P. Ballerini, G. Sabatino, M. P. Rathbone, M. D'Onofrio, F. Caciagli and P. Di Iorio This is the conclusion: The successful use of xanthine derivatives such as propentofylline or AIT-082 in the experimental treatment of human neurodegenerative disorders opens a new era in the development of therapeutic strategies based on purine derivatives. The data reviewed in this paper indicates that this may be just the beginning of an interesting and rewarding approach for the therapy of many diverse neurological problems.